Books on the topic 'Ankylotic'

To see the other types of publications on this topic, follow the link: Ankylotic.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 22 books for your research on the topic 'Ankylotic.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Sieper, Joachim. Ankylosing spondylitis: In clinical practice. [London]: Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

van, Royen Barend J., and Dijkmans B. A. C, eds. Ankylosing spondylitis: Diagnosis and management. New York: Taylor & Francis, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Yao tong, jian ying ti cao liao fa. Xianggang: Xianggang de li shu ju, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Weisman, Michael H. Ankylosing spondylitis. Oxford: Oxford University Press, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Khan, Muhammad Asim. Ankylosing spondylitis. Oxford: Oxford University Press, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ankylosing spondylitis. Oxford: Oxford University Press, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Campbell, Karen Marie. Characterization of ankylosis in traumatized permanent incisors. 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ankylosing Spondylitis: Symptoms, Treatment and Potential Complications. Nova Science Pub Inc, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Barend J. van Royen (Editor) and Ben A. C. Dijkmans (Editor), eds. Ankylosing Spondylitis: Diagnosis and Management. Informa Healthcare, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Weisman, Michael H. Ankylosing Spondylitis. Oxford University Press, Incorporated, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Weisman, Michael H. Ankylosing Spondylitis. Oxford University Press, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Ebringer, Alan. Ankylosing Spondylitis and Klebsiella. Springer London, Limited, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Ebringer, Alan. Ankylosing Spondylitis and Klebsiella. Springer London, Limited, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Ankylosing Spondylitis And Klebsiella. Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Weisman, Michael H., John D. Reveille, and Desiree van der Heijde. Ankylosing Spondylitis and the Spondyloarthropathies: A Companion to Rheumatology 3E (Companion to Rheumatology). Mosby, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Grandhe, Radhika P., Matthew Valeriano, and Dmitri Souza. Mechanical Chronic Jaw Pain. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190271787.003.0003.

Full text
Abstract:
Mechanical jaw pain and temporomandibular joint (TMJ) disorders are the most common causes of nondental orofacial pain. The pain can originate from the joint structures or from the muscles of mastication. Diagnosis is based predominantly on the clinical history and exam findings, but imaging is indicated in certain circumstances. Secondary causes of chronic jaw pain must be sought out and meticulously ruled out. Patients presenting with TMJ pain have a high prevalence of fibromyalgia and other chronic pain conditions. Multidisciplinary treatment involving medications, minimizing parafunctional habits, oral splints, physical therapy, psychotherapy, and injections forms the cornerstone of management of this complex condition. Surgery is indicated in select conditions, such as ankylosis of the joint or tumors.
APA, Harvard, Vancouver, ISO, and other styles
17

Khan, Muhammad Asim. Clinical features. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198734444.003.0011.

Full text
Abstract:
The leading chronic progressive inflammatory disease of the sacroiliac joints and the spinal column, traditionally known as ankylosing spondylitis (AS), is a relatively common but insidious rheumatic disease that can cause progressive limitation of physical function. It is a prototype of related forms of arthritis, grouped under the term spondyloarthritis that is subdivided into predominantly axial and predominantly peripheral forms. This chapter details the clinical features of axial spondyloarthritis, a term that encompasses ankylosing spondylitis. There is a predilection for the inflammation to affect sites where the tendons and ligaments attach to the bones (entheses) and can result in gradual and progressive spinal ankylosis, with resultant physical deformity. The disease may present with a wide spectrum of clinical features, both articular and extra-articular, and can be difficult to diagnose in early stages.
APA, Harvard, Vancouver, ISO, and other styles
18

Lories, Rik J., and Georg Schett. Pathology: bone. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198734444.003.0010.

Full text
Abstract:
Axial spondyloarthritis is associated with different types of skeletal damage. Inflammation at the affected sites is linked with both loss of trabecular bone and new bone formation on the cortical side, potentially leading to joint or spine ankylosis. Both aspects of the disease can result in a significant burden for the patient. Bone loss is directly linked to proinflammatory cytokines and activation of osteoclasts. Control of inflammation is therefore the best strategy to prevent loss of bone. The nature of the new bone formation process is less defined. A prominent role for developmental signalling pathways has been proposed. Current therapies have limited or no impact on this process. However, emerging data suggest that early control of disease activity may be part of a window of opportunity to prevent structural damage, as biomechanical factors and instability following inflammation may also play a role.
APA, Harvard, Vancouver, ISO, and other styles
19

Lories, Rik. Mechanisms of bone destruction and proliferation in psoriatic arthritis. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198737582.003.0008.

Full text
Abstract:
Psoriatic arthritis is a chronic inflammatory joint disease that can affect both the peripheral and axial skeleton. The clinical presentation of psoriatic arthritis is very heterogeneous and different subforms have been described. Structural damage to the joint is a feared complication of psoriatic arthritis. The severity of joint inflammation and subsequent damage can range from mild to extreme. Over the last decade, insights into the molecular and cellular mechanisms that underlie the skeletal changes in psoriatic arthritis have gradually increased although translational validation of concepts using patient-derived materials still lags behind. Current treatment strategies directed against key mediators of inflammation appear to have good effects on joint destruction, but their short and long-term impact on new bone formation and ankylosis is still unclear. The identification of the role that key growth factors play in the latter process identifies new opportunities for therapeutic interventions.
APA, Harvard, Vancouver, ISO, and other styles
20

Tillett, William, and Neil McHugh. Plain radiography. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198737582.003.0016.

Full text
Abstract:
Psoriatic arthritis is a destructive inflammatory arthritis that can affect the peripheral and axial skeleton of patients with psoriasis. Plain radiography has formed an important part in defining psoriatic arthritis as a distinct clinical entity, from early work reporting on distinguishing features to more recent inclusion of osteoproliferation in the CASPAR classification criteria. Plain radiography is accessible, inexpensive and remains the standard measure of assessing damage in inflammatory arthritis. Originally considered a benign disease psoriatic arthritis is now recognised to be destructive and progressive, though not as aggressive as rheumatoid arthritis. Peripheral joint damage is characterised by erosions, joint space narrowing, osteoproliferation, osteolysis and ankylosis. Approximately twenty percent of patients have erosive disease at diagnosis progressing to approximately half of all patients by three years disease duration. In its most severe form, psoriatic arthritis mutilans, digits become shortened from gross bone resorption (osteolyisis) leading to severe functional impairment and disability. Spondyloarthritis may affect between 25-70% of patients with PsA. The radiographic features of Psoriatic Spondyloarthritis differ from Ankylosing Spondylitis, in that sacroiliitis is often asymmetrical and less severe, the cervical spine is frequently involved and syndesmophytes are asymmetrical and para-marginal. Overall radiographic features are less severe than ankylosing spondylitis. The natural history of both peripheral and axial radiographic damage in psoriatic arthritis in the modern era of early diagnosis, tight disease control and biologic drugs has yet to be established.
APA, Harvard, Vancouver, ISO, and other styles
21

Sieper, Joachim. Ankylosing spondylitis. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0113.

Full text
Abstract:
Ankylosing spondylitis (AS) is a chronic inflammatory disease predominantly of the sacroiliac joint (SIJ) and the spine. It starts normally in the second decade of life and has a slight male predominance. The prevalence is between 0.2 and 0.8% and is strongly dependent on the prevalence of HLA B27 in a given population. For the diagnosis of AS, the presence of radiographic sacroiliitis is mandatory. However, radiographs do not detect active inflammation but only structural bony damage. Most recently new classification criteria for axial spondyloarthritis (SpA) have been developed by the Assessement of Spondylo-Arthritis international Society (ASAS) which cover AS but also the earlier form of non-radiographic axial SpA. MRI has become an important new tool for the detection of subchondral bone marrow inflammation in SIJ and spine and has become increasingly important for an early diagnosis. HLA B27 plays a central role in the pathogenesis but its exact interaction with the immune system has not yet been clarified. Besides pain and stiffness in the axial skeleton patients suffer also from periods of peripheral arthritis, enthesitis, and uveitis. New bone formation as a reaction to inflammation and subsequent ankylosis of the spine determine long-term outcome in a subgroup of patients. Currently only non-steroidal anti-inflammatory drugs (NSAIDs) and tumour necrosis factor (TNF) blockers have been proven to be effective in the medical treatment of axial SpA, and international ASAS recommendations for the structured management of axial SpA have been published based on these two types of drugs. Conventional disease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate are not effective.
APA, Harvard, Vancouver, ISO, and other styles
22

Sieper, Joachim. Axial spondyloarthropathies. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199642489.003.0113_update_003.

Full text
Abstract:
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease predominantly of the sacroiliac joint (SIJ) and the spine. It starts normally in the second decade of life and has a slight male predominance. The prevalence is between 0.2% and 0.8% and is strongly dependent on the prevalence of HLA-B27 in a given population. AxSpA can be split in patients with radiographic axSpA (also termed ankylosing spondylitis (AS)) and in patients with non-radiographic axSpA (nr-axSpA). For the diagnosis of AS, the presence of radiographic sacroiliitis is mandatory. However, radiographs do not detect active inflammation but only structural bony damage. Most recently new classification criteria for axSpA have been developed by the Assessment of Spondylo-Arthritis International Society (ASAS) which cover AS but also the earlier form of nr-axSpA. MRI has become an important new tool for the detection of subchondral bone marrow inflammation in SIJ and spine and has become increasingly important for an early diagnosis. HLA-B27 plays a central role in the pathogenesis but its exact interaction with the immune system has not yet been clarified. Besides pain and stiffness in the axial skeleton patients suffer also from periods of peripheral arthritis, enthesitis, and uveitis. New bone formation as a reaction to inflammation and subsequent ankylosis of the spine determine long-term outcome in a subgroup of patients. Currently only non-steroidal anti-inflammatory drugs (NSAIDs) and tumour necrosis factor (TNF) blockers have been proven to be effective in the medical treatment of axial SpA, and international ASAS recommendations for the structured management of axial SpA have been published based on these two types of drugs. Conventional disease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate are not effective.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography